Echocardiography Criteria for MitraClip Eligibility
MitraClip candidacy requires specific echocardiographic parameters that differ between primary and secondary mitral regurgitation, with the most critical being: mitral valve area ≥4.0 cm², mean transmitral gradient <4 mm Hg, grasping zone length >10 mm, and absence of severe calcification in the grasping zone. 1
Universal Anatomic Requirements (Both Primary and Secondary MR)
The following criteria apply regardless of MR etiology:
Location and Calcification
- Favorable: Noncommissural pathology (medial, middle, or lateral segments)
- Unfavorable: Commissural segments, leaflet perforations, or clefts
- Favorable: No or minimal calcification
- Unfavorable: Severe leaflet calcification in the grasping zone or severe annular calcification 1
Hemodynamic Parameters
- Mean transmitral gradient: Must be <4 mm Hg (favorable)
- Mitral valve area (MVA): Must be ≥4.0 cm² (favorable)
- Gradients >5 mm Hg or MVA <4.0 cm² are unfavorable due to risk of iatrogenic mitral stenosis 1
Grasping Zone
- Favorable: Grasping zone length >10 mm
- Unfavorable: Grasping zone length <7 mm 1
Primary MR-Specific Criteria
For degenerative/primary mitral regurgitation, additional anatomic features determine feasibility:
Favorable Features
- Flail width <15 mm
- Flail gap <10 mm
- Single segment pathology
- Normal leaflet thickness 1
Unfavorable Features
- Flail width >15 mm AND flail gap >10 mm
- Multisegment pathology
- Highly mobile flail leaflet with multiple ruptured chords
- Severely and diffusely thickened leaflets (≥5 mm in diastole) with redundant leaflets (Barlow's type valve)
- Left ventricular end-systolic diameter (LVESD) >55 mm 1
Secondary MR-Specific Criteria
For functional/secondary mitral regurgitation:
Favorable Features
- Coaptation depth <11 mm
- Coaptation length (overlap length) ≥2 mm 1
Unfavorable Features
- LVESD >70 mm 1
Important Clinical Context
The 2020 ACC guidelines emphasize that experienced operators at comprehensive valve centers may achieve good procedural results in selected cases with unfavorable anatomic features 1, acknowledging that these criteria continue to evolve. Research has demonstrated that patients treated outside traditional EVEREST trial criteria can achieve comparable safety and efficacy outcomes through 12 months 2.
Critical Pitfalls to Avoid
- Underestimating mitral stenosis risk: Always assess baseline MVA and gradients carefully, as multiple clips further reduce effective orifice area
- Commissural pathology: These locations are technically challenging and associated with lower success rates
- Severe calcification: Particularly in the grasping zone, this prevents adequate leaflet capture
- Barlow's disease with excessive tissue: Severely redundant, thickened leaflets (>5 mm) make durable repair difficult 1
The guidelines note that rigorous echocardiographic assessment and multidisciplinary team consensus are critically dependent for appropriate patient selection 1. Transesophageal echocardiography is essential for both screening and intraprocedural guidance 3.